USPTO serial 97134294
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Roche Diagnostics Operations, Inc.
Indianapolis, IN
Other trademarks owned by Roche Diagnostics Operations, Inc.
Roche Diagnostics Operations, Inc.
Indianapolis, IN
Other trademarks owned by Roche Diagnostics Operations, Inc.
Roche Diagnostics Operations, Inc.
Indianapolis, IN
Other trademarks owned by Roche Diagnostics Operations, Inc.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mona Gupta
Mona Gupta Roche Diagnostics Operations, Inc.9115 Hague RoadIndianapolis, IN 46250United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biological and biochemical preparations for scientific and research purposes; Assays and reagents for scientific and research purposes; In vitro diagnostic agents for scientific and research purposes; Control solutions for calibration and monitoring the accuracy and function of laboratory instruments and test results; Assays and reagents for scientific or medical research use; Kits consisting primarily of reagents and diagnostic preparations for research purpose | ACTIVE | Sep 29, 1980 |
| 005 | Chemical, biological and biochemical preparations for the analysis of biological samples for medical purposes; medical diagnostic assays and reagents for the analysis of biological samples for clinical or medical purposes; Diagnostic reagents and preparations for medical purposes; In vitro diagnostic agents for the analysis of biological samples for medical purposes; Kits consisting primarily of reagents and diagnostic preparations for clinical and medical diagnostic purposes | ACTIVE | Feb 9, 1996 |
| 009 | Laboratory instruments for use in research and science, namely, analyzers for the analysis of biological samples for scientific or medical research use; Laboratory instruments, namely, clinical chemistry analyzers and immunochemistry analyzers for the analysis of biological samples for the presence, absence, or quantity of medically significant analytes for scientific or medical research purposes; Laboratory equipment, namely, automated sample handling equipment comprised of recorded software for automating diagnostic laboratory processes, not for medical purposes and bar code readers; Downloadable computer software for the provision of automated diagnostic laboratory processes for medical and diagnostic purposes; Downloadable computer software for use with laboratory instruments, namely, for use in providing remote automated control, connection, data analysis and data management between central laboratory instrumentation and remote clinical laboratory instrumentation; Computer hardware and downloadable computer software for collecting, storing, analyzing and reporting biological information for use in the fields of scientific, diagnostics and clinical research; computer hardware and downloadable computer software for sample tracking and for managing projects, laboratory workflow and data for use in the fields of scientific, diagnostic and clinical research; computer hardware and downloadable computer software for collecting, storing, analyzing and reporting biological information, sample tracking, managing products, laboratory workflow and data for clinical diagnostic purposes | ACTIVE | Dec 31, 1995 |
| 010 | Medical apparatus and instruments for medical and diagnostic purposes for the analysis of biological samples; Medical apparatus, namely, clinical chemistry analyzers and immunochemistry analyzers for use in the analysis of biological samples for the presence, absence, or quantity of medically significant analytes for clinical medical diagnostic purposes | ACTIVE | May 21, 1997 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 9, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 9, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 9, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 10, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 10, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 25, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 25, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 5, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 19, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 17, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 17, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 17, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 17, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 17, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 17, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 17, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 20, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 20, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 20, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 14, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 24, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 23, 2021 | NWAP | NEW APPLICATION ENTERED | — |